Cytosorbents Crp
CTSO
$3.19-7.80%
Delayed · as of Oct 14, 2026, 2:15 PM ET
Mkt cap
$28.82M
EV/Sales
1.06
P/E ratio
N/A
FY2025 Revenue
$37.06M
EPS (TTM)
$-0.29
Gross Margin (FY2025)
71.48%
Profit Margin (FY2025)
-22.12%
Beta
1.44
Div yield
N/A
Sector
Healthcare
Cytosorbents Crp (CTSO) is a medical devices company listed on US.
Latest reported CTSO revenue for 2025-12-31 was $37.1M. Net income was -$8.2M. Revenue was up 4.1% from 2024-12-31 to 2025-12-31. CTSO currently screens at market cap $28.8M.
Use this CTSO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CTSO income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Cytosorbents Crp (CTSO) is a medical devices company in the Healthcare sector.
Latest cached Cytosorbents Crp (CTSO) revenue for Dec 31, 2025 was $37.1M. Net income was -$8.2M. Statements: https://lician.com/financials/ctso
Cytosorbents Crp (CTSO) market capitalization is $28.8M on the latest cached snapshot.
Cytosorbents Crp (CTSO) cached previous close $3.46; day range $3.04 – $3.46; volume 12,274. Session quote: https://lician.com/quote/ctso
Cytosorbents Crp (CTSO) latest cached earnings event is "CTSO earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CTSO filing is 8-K · Sep 23, 2026. Filings: https://lician.com/sec/ctso